SCHEMBL23003602

SCHEMBL23003602

CC1CS(O)(O)CCN1/N=C/c1ccc([N+](=O)[O-])o1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 8/20 0.78
▸ ALDH1A1 P00352 5/20 0.78
▸ MITF O75030 2/20 0.50
▸ MAPT P10636 4/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ TP53 P04637 3/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ HIF1A Q16665 2/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ TDP1 Q9NUW8 5/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ XBP1 P17861 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23003603 1.00 LMNA (0.78) LMNAALDH1A1MITFMAPTSMN1; SMN2
Nifurtimox SCHEMBL1650162 0.88 LMNA (1.00) LMNAALDH1A1MITFMAPTSMN1; SMN2
Nifurtimox SCHEMBL60840 0.88 LMNA (1.00) LMNAALDH1A1MITFMAPTSMN1; SMN2
Nifurtimox SCHEMBL60839 0.88 LMNA (1.00) LMNAALDH1A1MITFMAPTSMN1; SMN2
Nifurtimox SCHEMBL9910611 0.88 LMNA (1.00) LMNAALDH1A1MITFMAPTSMN1; SMN2
Nifurtimox SCHEMBL2326415 0.82 LMNA (0.83) LMNAALDH1A1MITFMAPTSMN1; SMN2
Nifurtimox SCHEMBL4727154 0.81 LMNA (0.85) LMNAALDH1A1MITFMAPTSMN1; SMN2
SCHEMBL12609083 0.79 LMNA (0.67) LMNAALDH1A1MITFMAPTSMN1; SMN2
SCHEMBL368127 0.77 LMNA (0.64) LMNAALDH1A1MITFMAPTSMN1; SMN2
SCHEMBL368126 0.77 LMNA (0.64) LMNAALDH1A1MITFMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330022-A1 COMPOSITIONS AND METHODS OF USING PROPYLENE SULFIDE-BASED POLYMERS FOR TREATMENT OF CHAGAS DISEASE UNIV NORTHWESTERN (US) 2023-10-19 — — US claimed
US-11737978-B2 Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease NORTHWESTERN UNIVERSITY (US) 2023-08-29 — — US claimed
US-20210052498-A1 COMPOSITIONS AND METHODS OF USING PROPYLENE SULFIDE-BASED POLYMERS FOR TREATMENT OF CHAGAS DISEASE NORTHWESTERN UNIVERSITY (US) 2021-02-25 — — US claimed
US-12311054-B2 Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease NORTHWESTERN UNIVERSITY (US) 2025-05-27 — — US disclosed
US-20230330022-A1 COMPOSITIONS AND METHODS OF USING PROPYLENE SULFIDE-BASED POLYMERS FOR TREATMENT OF CHAGAS DISEASE UNIV NORTHWESTERN (US) 2023-10-19 — — US disclosed
US-11737978-B2 Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease NORTHWESTERN UNIVERSITY (US) 2023-08-29 — — US disclosed
US-20210052498-A1 COMPOSITIONS AND METHODS OF USING PROPYLENE SULFIDE-BASED POLYMERS FOR TREATMENT OF CHAGAS DISEASE NORTHWESTERN UNIVERSITY (US) 2021-02-25 — — US disclosed
Send feedback